Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies

Affiliations

¹ Center for Cell-based Therapy, Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
² Graduate Program on Bioscience and Biotechnology, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão, Preto, Brazil.
³ In Situ Cell Therapy, SUPERA Innovation and Technology Park, Ribeirão Preto, São Paulo, Brazil.
⁴ Graduate Program on Basic and Applied, Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão, Preto, Brazil.
⁵ Department of Pharmaceutical Sciences, School ofPharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão, Preto, Brazil.
⁶ Center for Cell-based Therapy, Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. kelenfarias@fcfrp.usp.br.
⁷ Department of Clinical, Toxicological and Bromatological Analysis, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/n°, Ribeirão Preto, SP, 14010-903, Brazil. kelenfarias@fcfrp.usp.br.

Published Erratum

Nádia de Cássia Noronha et al. Stem Cell Res Ther. 2019.

. 2019 May 17;10(1):132.

doi: 10.1186/s13287-019-1259-0.

¹ Center for Cell-based Therapy, Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
² Graduate Program on Bioscience and Biotechnology, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão, Preto, Brazil.
³ In Situ Cell Therapy, SUPERA Innovation and Technology Park, Ribeirão Preto, São Paulo, Brazil.
⁴ Graduate Program on Basic and Applied, Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão, Preto, Brazil.
⁵ Department of Pharmaceutical Sciences, School ofPharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão, Preto, Brazil.
⁶ Center for Cell-based Therapy, Regional Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. kelenfarias@fcfrp.usp.br.
⁷ Department of Clinical, Toxicological and Bromatological Analysis, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café, s/n°, Ribeirão Preto, SP, 14010-903, Brazil. kelenfarias@fcfrp.usp.br.

Abstract

The original article [1] contained an error in the presentation of the first author's name, Nádia de Cássia Noronha. This has now been corrected.

Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.
Noronha NC, Mizukami A, Caliári-Oliveira C, Cominal JG, Rocha JLM, Covas DT, Swiech K, Malmegrim KCR. Noronha NC, et al. Stem Cell Res Ther. 2019 May 2;10(1):131. doi: 10.1186/s13287-019-1224-y. Stem Cell Res Ther. 2019. PMID: 31046833 Free PMC article. Review.

1. Noronha NC, et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Res Ther. 2019;10:131. doi: 10.1186/s13287-019-1224-y. - DOI - PMC - PubMed